Suppr超能文献

在视网膜母细胞瘤患者中发现的非RB1种系癌症易感变异。

Non-RB1 germline cancer predisposing variants found in retinoblastoma patients.

作者信息

Rodriguez Barreto Ana Maria, Walsh Michael F, Robbins Melissa A, Mauguen Audrey, Fiala Elise M, Olcese Cristina, Haggag-Lindgren Dianna, Mandelker Diana, Francis Jasmine H, Berger Michael F, Friedman Danielle Novetsky, Offit Kenneth, Abramson David H

机构信息

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

Genet Med Open. 2024 Mar 6;2:101836. doi: 10.1016/j.gimo.2024.101836. eCollection 2024.

Abstract

PURPOSE

It is well known that individuals with hereditary retinoblastoma are at lifelong high risk for developing subsequent malignant neoplasms (SMN). However, the role that non- germline variants play in tumorigenesis and SMN risk has not yet been studied. The purpose of this study is to report the frequency and spectrum of non- germline cancer predisposing variants in individuals with retinoblastoma (RB).

METHODS

Retrospective data collection from institutional electronic medical records of 94 individuals seen at our institution with personal history of retinoblastoma, who had undergone next-generation sequencing germline analysis.

RESULTS

The prevalence of individuals with cancer predisposition was 57% (54/94). Of these individuals, 76% (41/54) had a pathogenic/likely pathogenic (P/LP) variant only in the gene, 9% (5/54) harbored a P/LP variant only in a non- gene, and 11% (6/54) had both. No difference was found between patients with and without non- variants when comparing demographic and clinical characteristics, including time to SMN. Variants were found in 7 different genes, with only 1 variant repeating 3 times.

CONCLUSION

In this small cohort of patients with retinoblastoma, non- variants did not appear to augment tumorigenesis or disease progression. Larger studies are required to determine associations between specific variants and development of SMN.

摘要

目的

众所周知,遗传性视网膜母细胞瘤患者终生都有发生后续恶性肿瘤(SMN)的高风险。然而,非胚系变异在肿瘤发生和SMN风险中所起的作用尚未得到研究。本研究的目的是报告视网膜母细胞瘤(RB)患者中非胚系癌症易感变异的频率和谱。

方法

从我们机构的电子病历中回顾性收集94例有视网膜母细胞瘤个人病史且接受过下一代测序胚系分析的患者的数据。

结果

癌症易感患者的患病率为57%(54/94)。在这些患者中,76%(41/54)仅在 基因中有一个致病/可能致病(P/LP)变异,9%(5/54)仅在一个非 基因中有一个P/LP变异,11%(6/54)两者都有。在比较人口统计学和临床特征(包括发生SMN的时间)时,有和无非 变异的患者之间未发现差异。在7个不同基因中发现了变异,只有1个变异重复出现3次。

结论

在这个小队列的视网膜母细胞瘤患者中,非 变异似乎并未增加肿瘤发生或疾病进展。需要更大规模的研究来确定特定变异与SMN发生之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/688a/11613778/2253cc659dd1/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验